Publications (9) MONICA SALDAÑA VALDERAS publications

filter_list

2025

  1. Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab

    Revista Alergia Mexico, Vol. 72, Núm. 1, pp. 76-79

2021

  1. Clinical investigation and informed consent form in times of COVID-19 pandemic. A vision from the comitee ethics of research

    Medicina Clinica

  2. Respiratory adverse events during upper digestive endoscopies in children under ketamine sedation

    Minerva Pediatrics, Vol. 73, Núm. 1, pp. 15-21

2019

  1. Hypersensitivity to alemtuzumab. A safe and effective desensitization protocol: A case report

    Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 4, pp. 1016-1020

  2. Topical Pharyngeal Lidocaine Reduces Respiratory Adverse Events During Upper Gastrointestinal Endoscopies Under Ketamine Sedation in Children

    Pediatric Drugs, Vol. 21, Núm. 1, pp. 25-31

2017

  1. Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease

    Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 5, pp. 653-655

2016

  1. Severe pneumonia by Mycoplasma as an adverse event of everolimus therapy in patients with tuberous sclerosis complex

    European Journal of Paediatric Neurology, Vol. 20, Núm. 5, pp. 758-760

2009

  1. Infraestructura y recursos de los comités éticos de investigación clínica en España

    Medicina Clinica, Vol. 132, Núm. 12, pp. 476-480

2006

  1. La atención farmacéutica

    Revista de la Sociedad Espanola del Dolor, Vol. 13, Núm. 4, pp. 213-215